Novo Nordisk's semaglutide shows potential against addiction
An analyst says it’s too early to say whether Novo Nordisk’s ”golden molecule” has commercial potential to treat addiction, however.
by dorthe bach, translated by daniel pedersen
Novo Nordisk’s active ingredient, semaglutide, could perhaps help curb addiction to nicotine, alcohol, and cocaine, reports Danish finance media Finans.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Jefferies: Semaglutide data is "reassuring"
For subscribers
